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Take-home message: A retrospective
analysis of US electronic health record
(EHR) data revealed that in patients meeting
systemic inflammatory response syndrome
(SIRS) criteria, greater chloride loads
received during crystalloid resuscitation were
associated with greater in-hospital mortality,
an effect that was found to be independent of
fluid volume administered. These data
support existing evidence that crystalloids
with lower chloride content may be
preferable for use in patients with SIRS.
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Abstract Purpose: Recent data
suggest that both elevated serum
chloride levels and volume overload
may be harmful during fluid resusci-
tation. The purpose of this study was
to examine the relationship between
the intravenous chloride load and in-
hospital mortality among patients
with systemic inflammatory response
syndrome (SIRS), with and without
adjustment for the crystalloid volume
administered. Methods: We con-
ducted a retrospective analysis of
109,836 patients C18 years old that
met criteria for SIRS and received
fluid resuscitation with crystalloids.
We examined the association between
changes in serum chloride concen-
tration, the administered chloride load
and fluid volume, and the ‘volume-
adjusted chloride load’ and in-hospi-
tal mortality. Results: In general,
increases in the serum chloride con-
centration were associated with
increased mortality. Mortality was
lowest (3.7 %) among patients with
minimal increases in serum chloride
concentration (0–10 mmol/L) and
when the total administered chloride
load was low (3.5 % among patients
receiving 100–200 mmol; P \ 0.05
versus patients receiv-
ing C500 mmol). After controlling
for crystalloid fluid volume, mortality
was lowest (2.6 %) when the volume-
adjusted chloride load was
105–115 mmol/L. With adjustment
for severity of illness, the odds of
mortality increased (1.094, 95 % CI
1.062, 1.127) with increasing volume-
adjusted chloride load (C105 mmol/
L). Conclusions: Among patients
with SIRS, a fluid resuscitation strat-
egy employing lower chloride loads
was associated with lower in-hospital
mortality. This association was inde-
pendent of the total fluid volume
administered and remained significant
after adjustment for severity of ill-
ness, supporting the hypothesis that
crystalloids with lower chloride con-
tent may be preferable for managing
patients with SIRS.
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Introduction
Large volumes of intravenous (IV) crystalloids are fre-
quently given for the purpose of resuscitating critically ill
or postoperative patients [1]. While there is general
agreement regarding the benefits of fluid resuscitation,
there is significant variation in the type and amount of
fluid used, and the debate regarding the ideal resuscitation
fluid is ongoing [2]. Crystalloids most commonly used for
resuscitation are 0.9 % ‘‘normal’’ saline, which contains
supra-physiologic levels of sodium and chloride
(154 mmol/L), and ‘‘balanced’’ crystalloids such as
Ringer’s lactate, Hartmann’s, Ringer’s acetate or Plasma-
Lyte (Baxter Healthcare, Deerfield, IL, USA), which
typically have more physiological electrolyte concentra-
tions (98–112 mmol/L chloride; 130–140 mmol/L
sodium) [1].
Recent guidelines recommend the use of balanced
crystalloids for fluid resuscitation; however, these guide-
lines have been scrutinized because of a lack of
supportive evidence from prospective randomized trials
[3, 4]. When compared to balanced crystalloids, 0.9 %
saline has been extensively studied in large randomized
trials in critically ill patients and remains widely used [5–
7]. Infusion of 0.9 % saline induces hyperchloraemia and
metabolic acidosis in healthy individuals and surgical
patients [8–13]. Similarly, resuscitation of critically ill
patients with crystalloids containing supra-physiologic
chloride concentrations has been associated with higher
rates of hyperchloraemia, metabolic acidosis and clinical
complications versus resuscitation with balanced crystal-
loids [14–19].
Recent studies indicate that elevated serum chloride is
associated with serious clinical consequences in certain
inpatient populations. Hyperchloraemia has been shown
to be independently associated with increased mortality in
intensive care unit (ICU) and postsurgical patients, and
the amount of chloride received via IV infusion has been
identified as an important and potentially modifiable
cause of hyperchloraemic acidosis [20, 21]. Fluid choice
may therefore impact outcomes in patients requiring
infusion of large IV fluid volumes.
While studies have examined mortality in patients
receiving crystalloids with different chloride concentra-
tions [11, 16, 22–25], the relative contributions of
chloride load and fluid volume to mortality risk remain
unclear. The current study examined data from a large US
electronic health record (EHR) database. We investigated
the association between chloride load and in-hospital
mortality among patients meeting systemic inflammatory
response syndrome (SIRS) criteria who received IV
crystalloids, with and without adjustment for the total
fluid volume administered. SIRS patients represent an
important population, given that they are frequently
administered large volumes of chloride-containing fluids,
as well as the known associations between hyperchlora-




This study retrospectively analysed prospectively col-
lected US inpatient data between 1 January 2009 and 31
March 2013, sourced from the HealthFacts (Cerner
Corp., Kansas City, MO) EHR database and was
approved by the Duke University IRB. Inclusion criteria
(Supplementary Fig. 1) were prospectively defined to
identify hypovolaemic patients requiring fluid resuscita-
tion, and included age C18 years; presence of SIRS
criteria (tachycardia [HR [ 90 bpm] plus any of the fol-
lowing: (1) temperature[38 or\36 C; (2) C20 breaths/
min or PaCO2 B 32 mmHg; (3) leukocytes C12,000 or
B4,000 cells/mm3); receipt of [500 mL crystalloid
resuscitation solution within 2 days of SIRS qualification
(C2 administrations [250 mL); and hospitalization
C24 h. Tachycardia was required for inclusion because it
is readily captured in the database and can be used as a
clinical marker for hypovolaemia [26]. Crystalloid
resuscitation solutions included 0.9 % saline, Ringer’s
lactate and other balanced crystalloids. Dextrose-con-
taining solutions (e.g. 5 % dextrose in water) were also
included in total fluid volume, but were considered
maintenance fluids and did not count toward resuscitation
volume inclusion requirements. Patients receiving any
fluid containing hydroxyl-ethyl starch or albumin, plasma
protein fraction (PPF), hypertonic saline or 0.45 % saline,
or receiving [1 L total fluid on the day preceding SIRS
qualification were excluded. Gelatins (Gelofusine,
Haemaccel) are unavailable in the USA, and were not
specified as exclusion criteria. Patients undergoing car-
diac procedures (Supplementary Table 1) were excluded,
as were patients with end-stage renal disease (ESRD;
ICD-9 585.6), since large-volume resuscitation is infre-
quently used for patients with ESRD.
Data source
HealthFacts is a de-identified, Health Insurance Porta-
bility and Accountability Act (HIPAA)-compliant, US
EHR database covering 486 clinical facilities and hospital
systems. The study dataset was extracted from the data-
base such that duplicates and entries with missing/
incomplete data were removed. Care was taken to avoid
multiple counts of patient encounters, such that the
dataset represents individual patients.
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Analysis and statistics
Patient demographics and surgical procedures undergone
prior to SIRS qualification and coded as primary or sec-
ondary were collected (Table 1). Primary discharge
diagnoses (final, billing, discharge), the most well-popu-
lated diagnosis fields in the database, are reported.
Elixhauser comorbidities were identified using Agency
for Healthcare Research and Quality (ARHQ) criteria and
comorbidity scores were calculated according to pub-
lished methodology [27, 28]. Baseline and peak chloride
concentrations were defined as the lowest concentration
on the day of SIRS qualification and highest concentration
within 72 h following SIRS qualification, respectively.
Change in concentration was defined as the difference
between baseline and peak values.
Total IV fluid volumes and chloride/sodium loads
were examined for the day preceding SIRS qualification
for inclusion/exclusion, and from the day of SIRS quali-
fication plus 3 days (72 h) for outcome analysis. Total
volumes were determined by summing volumes for all
resuscitation and maintenance solutions with product size
[250 mL, in order to avoid volumes commonly used for
drug delivery/admixture. Volumes were determined by
(1) the EHR ‘‘order volume’’ field, or (2) label bag vol-
ume for the National Drug Code (NDC) for the order.
Total chloride load was calculated by summing the
chloride content for all solutions[250 mL. Chloride load
was adjusted for fluid volume received by dividing total
mmol chloride by total fluid volume. We refer to this
measure, expressed in mmol/L, as the ‘‘volume-adjusted
chloride load.’’ ‘‘Volume-adjusted sodium load’’ was
determined using the same methodology.
Patients were prospectively grouped in 10 mmol/L
increments for analysis of serum chloride concentration
and volume-adjusted chloride or sodium load, 100 mmol
increments for analysis of chloride load, and 1,000 mL
increments for analysis of fluid volume. Mortality was
determined by the database discharge value of
‘‘deceased,’’ and rates were compared between groups
using a two-proportion z test. To control for multiple
comparisons, a Bonferroni correction was applied to
calculated P values by multiplying by the number of
pairwise comparisons. A P value \0.05 was used to
define statistical significance. Regression functions and
95 % confidence intervals were weighted on the basis of
the number of patients in each group, and appropriateness
of fit was assessed using the coefficient of determination
(R2) and P value of the regression model.
Mortality odds ratios (ORs) associated with volume-
adjusted chloride load were calculated with and without
adjustment for severity of illness using the acute physi-
ology score (APS) [29]. ORs represent mortality odds
associated with a 10 mmol/L incremental increase in
volume-adjusted chloride load (for data points \105 and
C105 mmol/L). Post hoc analysis examined ORs associ-
ated with a 1 mmol/L incremental increase in volume-
adjusted chloride load for data below, within, and above
the 98–110 mmol/L range, which is the normal serum
chloride range reported by hospitals in the database.
Table 1 Summary of patient characteristics
Patient characteristic All patients
(n = 109,836)
Age
Mean (SD) 58.9 (18.8)
Median (range) 60 (18–90)
18-50 years, n (%) 35,635 (32.4)
51–64 years, n (%) 28,673 (26.1)
C65 years, n (%) 45,528 (41.5)
Gendera
Female, n (%) 60,124 (54.7)
Male, n (%) 49,658 (45.2)
Race
White, n (%) 71,880 (65.4)
Black, n (%) 29,143 (26.5)
Hispanic, n (%) 1,911 (1.7)
Asian/Pacific, n (%) 1,325 (1.2)
Other, n (%) 4,250 (3.9)
Not specified, n (%) 1,327 (1.2)
Most common primary discharge diagnosesb,c
Pneumonia, n (%) 10,075 (9.2)
Septicaemia, n (%) 7,454 (6.8)
General symptoms, n (%) 7,295 (6.6)
Symptoms involving respiratory system and other
chest symptoms, n (%)
6,962 (6.3)
Other symptoms involving abdomen and pelvis,
n (%)
5,600 (5.1)
Patients undergoing surgical procedure prior to
SIRS qualification, n (%)d
1,562 (1.4)
APS
Mean (SD) 7 (6)
Median (range) 6 (0–45)
Elixhauser comorbidity score
Mean (SD) 4 (7)
Median (range) 3 (-18 to 54)
APS acute physiology score
a Gender not specified for 54 patients
b Primary discharge diagnoses present in C5 % of patients (pri-
mary discharge diagnosis reported in database for 94.7 % of study
population)
c Pneumonia includes pneumonia organism unspecified, bacterial
pneumonia organism unspecified, viral pneumonia organism
unspecified; septicaemia includes unspecified septicaemia, septi-
caemia due to Gram-negative organism, streptococcal septicaemia;
general symptoms include generalized pain, malaise and fatigue,
altered mental status; symptoms involving respiratory system and
other chest symptoms include shortness of breath, chest pain; other
symptoms involving abdomen and pelvis include abdominal pain,
swelling, ascites
d Most common surgical procedures: total knee replacement
(n = 126), open reduction of fracture of femur with internal fixa-
tion (n = 57), closure of skin and subcutaneous tissue (other sites)
(n = 54), temporary tracheostomy (n = 50), other lysis of perito-




Overall, 109,836 patients from 124 hospitals were inclu-
ded in the analysis based on the defined inclusion criteria.
Mean age was 58.9 ± 18.8 years. In total, 41.5 %
(n = 45,528) of patients were C65 years old and 54.7 %
(n = 60,124) were female (Table 1). The most common
primary discharge diagnoses were pneumonia, septicae-
mia, general symptoms, symptoms involving respiratory
system and other chest symptoms, and other symptoms
involving abdomen and pelvis. Overall, 1,562 patients
(1.4 %) underwent a surgical procedure prior to SIRS
qualification. Mean APS was 7 ± 6 and mean Elixhauser
comorbidity score was 4 ± 7. Supplementary Tables 2
and 3 present patient characteristics stratified by fluid
volume.
Serum chloride and in-hospital mortality
The majority of patients (n = 108,110; 99.3 %) had a
baseline serum chloride concentration between 80 and
120 mmol/L. In-hospital mortality was lowest among
patients with baseline chloride concentrations of
100–110 mmol/L (3.4 %) and highest among patients
with 130–140 mmol/L baseline concentrations (31.1 %).
Regression analysis indicated that in-hospital mortality
increased sharply in patients with pre-resuscitation base-
line serum concentrations C110 mmol/L (Supplementary
Fig. 2a). Pairwise comparisons revealed that mortality
was significantly lower among patients with a
100–110 mmol/L baseline serum chloride concentration
versus groups with concentrations C110 or
80–100 mmol/L (P \ 0.001 for all pairwise compari-
sons). A very small fraction of patients (\1 %) had
particularly low baseline chloride (70–80 mmol/L), but
the sample size was too small to detect a significant
association with mortality versus patients with
100–110 mmol/L baseline concentrations (P [ 0.99).
Regarding peak serum chloride concentration, in-hospital
mortality was lowest among patients with peak concen-
trations in the range of 100–110 mmol/L (3.0 %) and
highest among patients with peak concentrations of
140–150 mmol/L (33.3 %; Supplementary Fig. 2b).
Larger positive shifts in serum chloride (i.e. larger
increases from baseline) were associated with higher in-
hospital mortality rates (Fig. 1), and regression analysis
indicated a strong linear relationship (R2 = 0.97;
P \ 0.001). Patients with the smallest increase in serum
chloride concentration (0–10 mmol/L) had the lowest
observed in-hospital mortality (3.7 %), and mortality
increased significantly as the change in serum chloride
increased. Mortality rate was 7.2 % among patients with
shifts of 10–20 mmol/L, 9.2 % among patients with shifts
of 20–30 mmol/L and 9.7 % among patients with shifts of
30–40 mmol/L (P \ 0.001 for pairwise comparisons
versus 0–10 mmol/L group).
Chloride load and in-hospital mortality: adjustment
for fluid volume
Examination of in-hospital mortality versus total chloride
received revealed that mortality increased with higher
total IV chloride load (R2 = 0.91, P \ 0.001; Fig. 2a).
Mortality was lowest among patients who received low
total amounts of chloride (3.5 % among patients receiving
100–200 mmol versus 9.5 % among patients receiving
[1,400 mmol; P = 0.028). Regression analysis also
suggested that larger fluid volumes were associated with
higher in-hospital mortality (R2 = 0.97, P \ 0.001;
Fig. 2b). The lowest mortality rate was observed among
patients receiving 1,000–2,000 mL IV fluid (3.7 %;
P \ 0.05 for pairwise comparisons with volume groups
C3,000 mL), while patients receiving 11,000–12,000 mL
had the highest observed mortality rate (10.8 %; P \ 0.05
for pairwise comparisons with volume groups
\5,000 mL). Hence, increasing chloride load and total
volume appear to be independently associated with higher
in-hospital mortality.
Because total fluid volume received—and therefore
chloride load—may be associated with severity of illness,
Fig. 1 Relationship between the change in serum chloride con-
centration (D serum [Cl-]) and in-hospital mortality in patients
meeting SIRS criteria and receiving[500 mL IV crystalloid fluids
within 2 days of SIRS qualification. Overall, 99.8 % of patients
(n = 109,658) experienced a change in serum chloride of
0–30 mmol/L. Data are fitted with a linear function (solid line),
weighted on the basis of the number of patients in each D serum
[Cl-] group. Dashed lines represent 95 % confidence interval
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we examined the relationship between chloride load and
in-hospital mortality after accounting for fluid volumes,
first by making comparisons within strata of resuscitation
fluid volume received, and second by examining the
association between volume-adjusted chloride load and
mortality. Broadly, mortality tended to increase with
greater chloride load within each resuscitation fluid vol-
ume stratum (Fig. 3), with the only exception being
within patients receiving \1,500 mL. With respect to
volume-adjusted chloride load, in-hospital mortality was
lowest (2.6 %) among patients receiving 105–115 mmol/
L. Regression analysis suggested that mortality increased
as patients received volume-adjusted chloride loads
C105 mmol/L (R2 = 0.82, P \ 0.001; Fig. 4). Patients
with the lowest volume-adjusted chloride loads
(\105 mmol/L), who accounted for a small proportion
(\2.5 %) of the study population, represented an excep-
tion to this trend (mortality decreased as volume-adjusted
chloride load increased). However, the trend observed in
[97.5 % of the population was that after volume
adjustment, mortality rates increased with greater vol-
ume-adjusted chloride loads. Mortality OR associated
with an incremental 10 mmol/L increase in volume-
adjusted chloride load was 0.814 [0.762, 0.870] and 1.095
[1.065, 1.127] for patients with volume-adjusted chloride
loads \105 and C105 mmol/L, respectively (Fig. 4).
Thus, mortality decreased with greater volume-adjusted
chloride load up to 105 mmol/L and increased with vol-
ume-adjusted chloride loads 105 mmol/L and higher.
Severity of illness adjustment using APS did not have a
meaningful impact on mortality ORs [\105 mmol/L:
0.888 (0.827, 0.957); C105 mmol/L: 1.094 (1.062,
1.127)], suggesting that the apparent association between
mortality and volume-adjusted chloride load is not
explained by severity of illness. Analysis using a multi-
variate model (Supplementary Table 4) similarly found
mortality ORs of 0.916 [0.844, 0.997] and 1.046 [1.013,
1.079] for patients receiving volume-adjusted chloride
loads \105 and C105 mmol/L, respectively, after APS
adjustment. Post hoc analysis of continuous data below,
within, and above the normal chloride range (Supple-
mentary Table 5) revealed that increasing volume-
adjusted chloride load was associated with APS-adjusted
ORs of 1.000 [0.973, 1.027], 1.027 [0.970, 1.086] and
1.011 [1.008, 1.014] for patients receiving \98, 98–110
and [110 mmol/L, respectively.
Fig. 2 Relationship between
chloride load received within
72 h following SIRS
qualification and in-hospital
mortality (a). Relationship
between IV fluid volume
received within 72 h of SIRS
qualification and in-hospital
mortality (b). Regression lines
(solid lines) in both panels
represent a cubic polynomial fit
and are weighted on basis of the
number of patients receiving
given amounts of total chloride
or IV fluid. Dashed lines
represent 95 % confidence
interval
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Examining mortality versus sodium load after
accounting for fluid volume showed that mortality tended
to increase with sodium load in patients receiving
[3,000 mL resuscitation fluids, but there was no associ-
ation in groups receiving lower volumes (Supplementary
Fig. 3). Mortality was lowest among patients receiving a
volume-adjusted sodium load of 135–145 mmol/L (Sup-
plementary Fig. 4) [30].
Discussion
This study demonstrates an association between greater
amounts of chloride received during crystalloid resusci-
tation and increased in-hospital mortality, even after
controlling for total fluid volume received. While previ-
ous studies have compared mortality in patients receiving
balanced versus unbalanced crystalloids [11, 16, 22–25],
this is, to our knowledge, the first study to specifically
examine whether the relationship between crystalloid
chloride content and mortality is attributable to the
chloride load independent of fluid volume.
The observed association between greater chloride
loads and increased in-hospital mortality is not entirely
surprising, since the infusion of chloride-rich fluids is
itself associated with hyperchloraemia [8–13], which has
been associated with a greater likelihood of poor patient
outcomes [20, 21]. Consistent with previous reports, this
study found elevated mortality rates in patients who
would generally be classified as hyperchloraemic [20, 21].
Similarly, large changes in serum chloride concentration,
suggesting a shift to a hyperchloraemic state, correlated
with greater in-hospital mortality, supporting the idea that
maintenance of physiologic serum chloride levels may be
important. These findings contribute to the growing
observational evidence of the potentially serious clinical
impact of using chloride-rich crystalloids. Two recent
studies using data from a large US claims database
demonstrated an elevated risk of several complications in
patients receiving 0.9 % saline versus a balanced crys-
talloid [18, 23].
In-hospital mortality was observed to increase with
greater total chloride loads. Similarly, mortality tended to
increase with increased total fluid volume, consistent with
findings from the FACTT (Fluid and Catheter Treatment
Trial) and trials in surgical patients showing associations
between fluid overload and morbidity and mortality [31–
33]. Our observations within defined volume strata and
based on volume-adjusted total chloride loads indicate
that mortality may be related to the chloride load inde-
pendent of fluid volume. An exception to the trend of
increasing mortality within resuscitation fluid volume
strata was observed among the lowest volume group
(\1,500 mL), which may reflect the low total chloride
loads received by patients in this group (0–300 mmol),
and further, the importance of appropriate fluid resusci-
tation in hyperchloraemic patients. The observed trend in
patients receiving C1,500 mL (increasing mortality with
increasing chloride load) may reflect the potential risks of
Fig. 3 Relationship between
chloride load received via IV
resuscitation fluids within 72 h
following SIRS qualification
and in-hospital mortality,
stratified by total resuscitation
fluid volume received. In the
\1,500 mL group, there was a
weak association between
increasing total chloride and
reduced mortality (weighted
linear fit; slope = -0.01,
R2 = 0.99). For the
1,500–3,000 through
6,000–7,500 mL groups, there
was an increasingly positive
association (increased mortality
with increasing chloride load)
for each incremental volume
increase (1,500–3,000 mL:
slope = 0.003, R2 = 0.11;
3,000–4,500 mL: slope = 0.01,
R2 = 0.60; 4,500–6,000 mL:
slope = 0.02, R2 = 0.76;
6,000–7,500 mL: slope = 0.03,
R2 = 0.89; [7,500 mL:
slope = 0.01, R2 = 0.32)
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resuscitation with chloride-liberal fluids. With respect to
volume-adjusted chloride load, in-hospital mortality was
generally low (\4 %) among patients receiving
105–145 mmol/L chloride, with the lowest mortality
among patients receiving 105–115 mmol/L. Post hoc
analysis found increasing mortality odds with increasing
volume-adjusted chloride load [110 mmol/L, indicating
potential risks associated with chloride loads exceeding
normal serum concentration ranges. These observations
are particularly meaningful given that balanced crystal-
loids with chloride concentrations in the normal
physiological range are readily available, though not
widely utilized among this patient population, as the large
majority ([80 %) of patients primarily receive 0.9 %
saline [1, 5]. While increasing fluid volume was associ-
ated with increased mortality (Fig. 2b), controlling for
total volume does not specifically control for severity of
illness. We therefore examined associations between
volume-adjusted chloride load and mortality by control-
ling for severity of illness using the APS. The lack of a
meaningful effect on mortality ORs suggests that the
association between volume-adjusted chloride load and
mortality was not driven by severity of illness.
It is noteworthy that mortality was elevated in the small
group of patients (\2.5 % of the study population) who
received relatively low volume-adjusted chloride loads
(\105 mmol/L). Potential explanations include the receipt
of relatively large proportions of dextrose-containing
maintenance fluids, which contain lower chloride con-
centrations, rather than active resuscitation. Particularly
high-acuity patients may have died before receiving ade-
quate resuscitation or fluid administration may have been
limited because of concerns related to comorbidities such
as congestive heart failure in which higher sodium loads
are not tolerated and carry a high mortality rate.
Recent evidence indicates risks associated with high
sodium loads and suggests that hyperchloraemic meta-
bolic acidosis and hypernatraemia may be independent
complications associated with fluid infusion [34]. While
our study found a potential association between sodium
load and mortality, the ability to fully separate sodium
load from volume and tonicity is limited, and this ques-
tion may warrant further study. Studies examining
outcomes in light of relative differences in chloride and
sodium load may provide important insights.
While the reasons for the association between
increased mortality and elevated chloride levels remain to
be fully elucidated, important clinical consequences of
hyperchloraemia are known [10, 12, 13, 20, 21, 35]. High
serum chloride concentrations following infusion of
0.9 % saline are associated with reduced renal artery flow
velocity, renal cortical tissue perfusion and longer time to
urination [10, 12, 13]. Additionally, animal studies have
implicated hyperchloraemia in effects on the immune
system [36, 37], altered blood oxygen binding [38] and
organ damage [39].
Fig. 4 Relationship between volume-adjusted chloride load
received within 72 h following SIRS qualification and in-hospital
mortality. Regression line (solid line) represents a cubic polynomial
fit and is weighted on the basis of the number of patients receiving
each given amount of volume-adjusted chloride. Dashed lines
represent 95 % confidence interval. Inset table presents unadjusted
and APS-adjusted mortality odds ratio (OR) associated with
10 mmol/L incremental increases in volume-adjusted chloride load
for patients with volume-adjusted chloride load \105 and
C105 mmol/L, respectively. Separate ORs were analysed for
patients receiving \105 and C105 mmol/L given that (1) [97 %
of patients received a volume-adjust chloride load C105 mmol/L,
(2) lowest mortality was observed in patients receiving
105–115 mmol/L chloride and (3) 105 mmol/L approximates the
established upper limit of normal serum chloride concentration [30]
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In summary, this study demonstrates an association
between IV chloride load and mortality in hospitalized
patients with SIRS, independent of total fluid volume.
Given the study’s predefined fluid inclusion criteria, our
findings may not be generalizable to all SIRS patients.
Still, these findings support existing published data
suggesting that fluid composition and volume both have
important effects on clinical outcomes. Because the
study was observational, the associations are hypothe-
sis-generating and highlight the need for randomized
controlled trials powered to detect outcome differences
in patients resuscitated using different crystalloids. A
multicentre study comparing 0.9 % saline and a bal-
anced crystalloid is underway [40]. When viewed
together with the existing literature, our findings may
not represent evidence that high-chloride solutions are
harmful ‘‘beyond a reasonable doubt’’ (they are obser-
vational), but the balance of probabilities appears to be
shifting away from high-chloride and toward low-
chloride solutions for first-line fluid resuscitation of
patients with SIRS.
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